BAJAJ BROKING

Notification
No new Notification messages
One Mobikwik Systems IPO is Open!
Apply for the One Mobikwik Systems IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
novartis india ltd. stock

NOVARTIS INDIA LTD. Share Price

1010.8 -12.04 (-1.17%)
Dec 11 2024 03:29 PM Pharmaceuticals NSE: NOVARTIND

NOVARTIS INDIA LTD. Share Price Update

As of the latest trading session, NOVARTIS INDIA LTD. share price is currently at 1010.8, which is down by -12.04 from its previous closing. Today, the stock has fluctuated between 1005.10 and 1024.95. Over the past year, NOVARTIS INDIA LTD. has achieved a return of 41.24 %. In the last month alone, the return has been -2.52 %. Read More...

NOVARTIS INDIA LTD. Performance

Day Range

Low1005.10 High1024.95
1012.25

52 Week Range

Low 699.00 High 1248.00
1012.25

NOVARTIS INDIA LTD. Share Price

500672

NOVARTIND

img img img img
No Data Available

Open Price

1023.00

Prev. Close

1022.85

Volume (Shares)

3882.00

Total traded value

39.54

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

NOVARTIS INDIA LTD. Fundamentals


(Standalone)

Market Cap (Cr) 2499.30
PE Ratio (TTM) 28.89
Book Value / Share 295.35
Beta 0.61
ROE 11.21%
EPS (TTM) 35.40
Dividend Yield 2.44%
Net Profit Qtr (Cr) 20.41

NOVARTIS INDIA LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 87.11
Operating Expense 69.87
Net Profit 20.41
Net Profit Margin (%) 23.43
Earnings Per Share (EPS) 8.27
EBITDA 28.29
Effective Tax Rate (%) 25.94
Particulars JUN 2024 (Values in Cr)
Revenue 92.29
Operating Expense 69.02
Net Profit 25.74
Net Profit Margin (%) 27.89
Earnings Per Share (EPS) 10.42
EBITDA 34.37
Effective Tax Rate (%) 23.57
Particulars MAR 2024 (Values in Cr)
Revenue 81.17
Operating Expense 70.25
Net Profit 14.68
Net Profit Margin (%) 18.08
Earnings Per Share (EPS) 5.95
EBITDA 21.63
Effective Tax Rate (%) 31.17
Particulars DEC 2023 (Values in Cr)
Revenue 84.54
Operating Expense 65.19
Net Profit 26.57
Net Profit Margin (%) 31.42
Earnings Per Share (EPS) 10.76
EBITDA 41.73
Effective Tax Rate (%) 35.68
Particulars SEP 2023 (Values in Cr)
Revenue 78.76
Operating Expense 63.21
Net Profit 23.68
Net Profit Margin (%) 30.06
Earnings Per Share (EPS) 9.59
EBITDA 33.79
Effective Tax Rate (%) 26.98
Particulars MAR 2024 (Values in Cr)
Revenue 335.07
Operating Expense 273.91
Net Profit 85.19
Net Profit Margin (%) 25.42
Earnings Per Share (EPS) 34.50
EBITDA 126.94
Effective Tax Rate (%) 30.64
Particulars MAR 2023 (Values in Cr)
Revenue 378.74
Operating Expense 321.47
Net Profit 103.36
Net Profit Margin (%) 27.29
Earnings Per Share (EPS) 41.86
EBITDA 123.19
Effective Tax Rate (%) 10.41
Particulars MAR 2022 (Values in Cr)
Revenue 399.87
Operating Expense 387.24
Net Profit -3.72
Net Profit Margin (%) -0.93
Earnings Per Share (EPS) -1.51
EBITDA 10.66
Effective Tax Rate (%) 2.61
Particulars MAR 2021 (Values in Cr)
Revenue 381.35
Operating Expense 374.40
Net Profit 20.90
Net Profit Margin (%) 5.48
Earnings Per Share (EPS) 8.46
EBITDA 59.87
Effective Tax Rate (%) 47.80
Particulars MAR 2020 (Values in Cr)
Revenue 438.25
Operating Expense 445.75
Net Profit 10.08
Net Profit Margin (%) 2.30
Earnings Per Share (EPS) 4.08
EBITDA 48.17
Effective Tax Rate (%) 64.80
Particulars MAR 2024 (Values in Cr)
Book Value / Share 301.79
ROE % 11.21
ROCE % 15.57
Total Debt to Total Equity 0.02
EBITDA Margin 37.88
Particulars MAR 2023 (Values in Cr)
Book Value / Share 314.29
ROE % 14.09
ROCE % 14.88
Total Debt to Total Equity 0.03
EBITDA Margin 32.53
Particulars MAR 2022 (Values in Cr)
Book Value / Share 280.27
ROE % 5.84
ROCE % 5.66
Total Debt to Total Equity 0.06
EBITDA Margin 13.75
Particulars MAR 2021 (Values in Cr)
Book Value / Share 288.16
ROE % 2.92
ROCE % 5.57
Total Debt to Total Equity 0.09
EBITDA Margin 15.70
Particulars MAR 2020 (Values in Cr)
Book Value / Share 292.03
ROE % 1.36
ROCE % 4.24
Total Debt to Total Equity 0.05
EBITDA Margin 10.99
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 596.08
Total Assets 924.93
Total Liabilities 924.93
Total Equity 744.82
Share Outstanding 24690797
Price to Book Ratio 3.41
Return on Assets (%) 9.21
Return on Capital (%) 11.44
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 555.94
Total Assets 982.94
Total Liabilities 982.94
Total Equity 775.66
Share Outstanding 24690797
Price to Book Ratio 1.80
Return on Assets (%) 10.51
Return on Capital (%) 13.33
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 517.63
Total Assets 957.57
Total Liabilities 957.57
Total Equity 691.70
Share Outstanding 24690797
Price to Book Ratio 2.11
Return on Assets (%) -0.38
Return on Capital (%) -0.54
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 498.88
Total Assets 1002.29
Total Liabilities 1002.29
Total Equity 711.19
Share Outstanding 24690797
Price to Book Ratio 1.92
Return on Assets (%) 2.08
Return on Capital (%) 2.94
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 581.91
Total Assets 1077.64
Total Liabilities 1077.64
Total Equity 720.73
Share Outstanding 24690797
Price to Book Ratio 1.72
Return on Assets (%) 0.93
Return on Capital (%) 1.4
Particulars MAR 2024 (Values in Cr)
Net Income 122.84
Cash from Operations 75.13
Cash from Investing 33.13
Cash from Financing -120.99
Net change in Cash 25.54
Free Cash Flow 75.13
Particulars MAR 2023 (Values in Cr)
Net Income 115.38
Cash from Operations 42.46
Cash from Investing -153.25
Cash from Financing -30.48
Net change in Cash -138.93
Free Cash Flow 42.77
Particulars MAR 2022 (Values in Cr)
Net Income -3.82
Cash from Operations 57.26
Cash from Investing 87.04
Cash from Financing -35.63
Net change in Cash 90.08
Free Cash Flow 57.76
Particulars MAR 2021 (Values in Cr)
Net Income 40.04
Cash from Operations -34.02
Cash from Investing 95.16
Cash from Financing -36.80
Net change in Cash -10.85
Free Cash Flow -33.93
Particulars MAR 2020 (Values in Cr)
Net Income 28.64
Cash from Operations 14.99
Cash from Investing 55.91
Cash from Financing -41.41
Net change in Cash -8.64
Free Cash Flow 15.99
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.90 37.87 3.59 505.01 37.54 / 77.70
BLISS GVS PHARMA LTD 155.50 19.46 1.62 1637.91 92.25 / 172.40
CIPLA LTD 1455.65 25.47 4.14 117560.12 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 414.95 144.08 4.20 1221.24 145.00 / 440.00
GLAXOSMITHKLINE PHARMA LT 2328.95 49.21 23.58 39453.82 1664.75 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.90 57.30 11.20 505.01 37.54 / 77.70
AMRUTAJAN HEALTH LTD 753.60 45.84 7.31 2178.71 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6634.15 128.84 24.41 16585.38 4050.15 / 8139.85
BLISS GVS PHARMA LTD 155.50 20.27 1.59 1637.91 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1034.10
  • 26 Days 1052.00
  • 10 Days 1043.80
  • 50 Days 1071.40
  • 12 Days 1041.60
  • 100 Days 1086.70
  • 20 Days 1050.50
  • 200 Days 1172.80
1018.12
PIVOT
First Resistance 1033.13
Second Resistance 1043.42
Third Resistance 1058.43
First Support 1007.83
Second Support 992.82
Third Support 982.53
RSI 42.56
MACD -10.41
Commodity Channel Index (CCI) -134.03
ADX 15.64
Williams % R -71.87

Over 1 Month

down

-2.52

Over 3 Months

down

-4.74

Over 6 Months

down

-4.09

Over 1 Year

down

41.24

Over 3 Years

down

8.41

Over 5 Years

down

8.43

NOVARTIS INDIA LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

NOVARTIS INDIA LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
28.6
Promoter Holdings
70.67
FII
0.18
DII
0.53
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Novartis Ag Shareholding of Promoter and Promoter Group 1.745068E7 70.68
Atul Limited Public Shareholding 374627.0 1.52

NOVARTIS INDIA LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-07-20 10.0 Final 2023-07-21 Equity shares 2023-07-20 37.5 Special 2023-07-21 Equity shares 2022-07-20 10.0 Final 2022-07-22 Equity shares 2021-08-17 10.0 Final 2021-08-20 Equity shares 2020-07-29 10.0 Final 2020-07-31 Equity shares 2019-07-31 10.0 Final 2019-08-02 Equity shares 2018-07-18 10.0 Final 2018-07-20 Equity shares 2017-07-19 10.0 Final 2017-07-21 Equity shares 2016-07-21 10.0 Final 2016-07-22 Equity shares 2015-07-14 10.0 Final 2015-07-16 Equity shares 2014-07-16 5.0 Final 2014-07-18 Equity shares 2013-07-16 10.0 Final 2013-07-18 Equity shares 2012-07-18 10.0 Final 2012-07-20 Equity shares 2011-07-18 10.0 Final 2011-07-20 Equity shares 2010-07-21 10.0 Final 2010-07-23 Equity shares 2009-07-08 10.0 Final 2009-07-10 Equity shares 2008-07-07 10.0 Final 2008-07-09 Equity shares 2007-03-22 10.0 Final 2007-03-23 Equity shares 2005-07-20 0.0 Final 2005-07-22 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About NOVARTIS INDIA LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by NOVARTIS INDIA LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Novartis India Ltd?

Answer Field

The share price of Novartis India Ltd for NSE is ₹ 672.25 and for BSE is ₹ 1012.25.

What is the Market Cap of Novartis India Ltd?

Answer Field

The market cap of Novartis India Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 24,99.30 Cr. as of now.

What is the 52 Week High and Low of Novartis India Ltd?

Answer Field

The 52 Week High and Low of Novartis India Ltd for NSE is ₹ 698.20 and ₹ 0.00 and for BSE is ₹ 1248.00 and ₹ 699.00.

How to Buy Novartis India Ltd share?

Answer Field

You can trade in Novartis India Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Novartis India Ltd?

Answer Field

The 1 year returns on the stock has been 41.24%.

What is the Current Share Price of Novartis India Ltd?

Answer Field

Novartis India Ltd share price is for NSE ₹ 672.25 & for BSE ₹ 1012.25 as on Dec 11 2024 03:29 PM.

What is the Market Cap of Novartis India Ltd Share?

Answer Field

The market cap of Novartis India Ltd for NSE ₹ 0.0 & for BSE ₹ 24,99.30 as on Dec 11 2024 03:29 PM.

What is the P/E Ratio of Novartis India Ltd Share?

Answer Field

As on Dec 11 2024 03:29 PM the price-to-earnings (PE) ratio for Novartis India Ltd share is 28.89.

What is the PB ratio of Novartis India Ltd Share?

Answer Field

As on Dec 11 2024 03:29 PM, the price-to-book (PB) ratio for Novartis India Ltd share is 295.35.

How to Buy Novartis India Ltd Share?

Answer Field

You can trade in Novartis India Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Novartis India Ltd Share on Bajaj Broking App?

Answer Field

To buy Novartis India Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Novartis India Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader